32 Result(s)

Article

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”

K. H. Begna, X. Xu, N. Gangat, H. Alkhateeb, M. M. Patnaik… in Blood Cancer Journal (2022)

Article

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

G Goyal, A C Bartley, M M Patnaik, M R Litzow, A Al-Kali, R S Go in Blood Cancer Journal (2017)

Article

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis

M M Patnaik, M M Timm, R Vallapureddy, T L Lasho, R P Ketterling… in Blood Cancer Journal (2017)

Article

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

Current prognostic models for myelodysplastic syndromes (MDS), including the Revised International Prognostic Scoring System (IPSS-R), do not account for host immunity. We retrospectively examined the prognost...

L Saeed, M M Patnaik, K H Begna, A Al-Kali, M R Litzow, C A Hanson… in Blood Cancer Journal (2017)

Article

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

M M Patnaik, M F Zahid, T L Lasho, C Finke, R L Ketterling… in Blood Cancer Journal (2016)

Article

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

N Gangat, M M Patnaik, K Begna, A Al-Kali, M R Litzow… in Blood Cancer Journal (2016)

Article

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

A Tefferi, A Al-Kali, K H Begna, M M Patnaik, T L Lasho, A Rizo… in Blood Cancer Journal (2016)

Article

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Chronic myelomonocytic leukemia (CMML) is a clonal stem cell disorder associated with peripheral blood monocytosis and an inherent tendency to transform to acute myeloid leukemia. CMML has overlap** features...

M M Patnaik, A Tefferi in Blood Cancer Journal (2016)

Article

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

Mutations involving epigenetic regulators (TET2~60% and ASXL1~40%) and splicing components (SRSF2~50%) are frequent in chronic myelomonocytic leukemia (CMML). On a 27-gene targeted capture panel performed on 175 ...

M M Patnaik, T L Lasho, P Vijayvargiya, C M Finke, C A Hanson… in Blood Cancer Journal (2016)

Article

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

Since its reclassification as a distinct disease entity, clinical research efforts have attempted to establish baseline characteristics and prognostic scoring systems for chronic myelomonocytic leukemia (CMML)...

E Padron, G Garcia-Manero, M M Patnaik, R Itzykson, T Lasho… in Blood Cancer Journal (2015)

Article

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26

J Perez Botero, J L Oliveira, D Chen, K K Reichard, D S Viswanatha… in Blood Cancer Journal (2015)

Article

Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Correction to: Blood Cancer Journal (2015) 4, e270; doi:10.1038/bcj.2014.90; published online 2 January 2015 Since publication, the publishers have identified that this article was incorrectly placed in volume...

M M Patnaik, E A Wassie, E Padron, F Onida, R Itzykson, T L Lasho… in Blood Cancer Journal (2015)

Article

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

In patients with chronic myelomonocytic leukemia (CMML), age>65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 ‘...

M M Patnaik, E A Wassie, E Padron, F Onida, R Itzykson, T L Lasho… in Blood Cancer Journal (2015)

Article

Erratum: Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Correction to: Leukemia (2013) 27, 1504–1510; doi:10.1038/leu.2013.88 Since the publication of this article, the authors have identified an error concerning to one of the author names. RS Komroji should have b...

M M Patnaik, E Padron, R R LaBorde, T L Lasho, C M Finke, C A Hanson… in Leukemia (2013)

Article

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

R R Laborde, M M Patnaik, T L Lasho, C M Finke, C A Hanson, R A Knudson… in Leukemia (2013)